Decreased in Liver Fibrosis in Patients with HCV/HIV Coinfection After Treatment with Sofosbuvir/Daclatasvir
Background: Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) co-infection increases the progression of liver fibrosis to advanced liver disease and death. The aim of this study is to determine whether decreased of liver fibrosis occur in HCV/HIV coinfection patients after therapy with Sofo...
| Prif Awduron: | , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
Interna Publishing
2020-07-01
|
| Cyfres: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.ina-jghe.com/index.php/jghe/article/view/702 |